NCT05717790 2023-02-08Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal CarcinomaFourth Affiliated Hospital of Guangxi Medical UniversityPhase NA Recruiting288 enrolled